Qualcomm CEO: The market is making ‘an absolute mistake’ on our stock

TheStreet.com

AbbVie’s Correction Appears to Be Over: Here’s Where the Stock Could Be Headed

AbbVie , the research-based biopharmaceutical company that was spun off from Abbott Laboratories in 2013, has made an impressive move higher the past nine years. Recently, ABBV pulled back from an April high but the correction is showing signs it is over. In the daily bar chart of ABBV, below, we can see that the shares declined below the 50-day moving average line and its slope is cresting.